MARKET INTRODUCTION
Polio vaccines are vaccines used to prevent poliomyelitis (polio). Two types are used an inactivated poliovirus given by injection (IPV) and a weakened poliovirus given by mouth (OPV). The World Health Organization (WHO) recommends all children aged 2 months, 4 months, 6-18 months and age ranging from 4 to 6 years be fully vaccinated against polio. Polio vaccines can be used as a single drug or mixed with a mixture of drugs. The combined polio vaccine drugs are used to fight against Diptheria, tetanus, and infections caused by the hepatitis B virus.
MARKET DYNAMICS
The polio vaccine market is anticipated to grow due to rising awareness of poliovirus diseases and the growing need for vaccinating children among nations. Moreover, increasing investments for the development of different types of polio vaccines and a rise in the number of annual dosage for polio vaccines around the globe is expected to benefit the growth of the market in the forecast period.
MARKET SCOPE
The "Polio Vaccine Market Analysis to 2028" is a specialized and in-depth study of the pharmaceutical industry with a special focus on the global market trend analysis. The report aims to provide an overview of in polio vaccine market with detailed market segmentation by type, application and geography. The polio vaccine market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading in polio vaccine market players and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The polio vaccine market is segmented on the basis of type and application. Based on type the market is segmented as inactivated polio vaccine (IPV) and oral polio vaccine (OPV). On the basis of application the market is categorized as public and private.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the in polio vaccine market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The polio vaccine market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting polio vaccine market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the polio vaccine market in these regions.

MARKET PLAYERS
The report covers key developments in the in polio vaccine market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from in polio vaccine market are anticipated to have lucrative growth opportunities in the future with the rising demand for in polio vaccine market in the global market. Below mentioned is the list of few companies engaged in the polio vaccine market.
The report also includes the profiles of key in polio vaccine market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
- Bibcol
- BIO-MED
- GlaxoSmithKline plc
- HAFFKINE BIO-PHARMACEUTICAL CORPORATION LTD
- IMBCA
- Panacea Biotec Ltd
- Pfizer Inc
- Sanofi
- Serum Institute of India Pvt. Ltd.
- Tiantan Biological
The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.